US-based Neuro-Horizon Pharma licenses promising compounds from NTU Singapore to combat multidrug-resistant tuberculosis - EurekAlert

A new series of chemical compounds that can kill multidrug-resistant tuberculosis (TB), have been developed and commercialised by a joint team from NTU Singapore and A*STAR Experimental Drug Development Centre. Licensing these compounds is US-based company Ne…

image: The above figure shows two forms of mycobacterial colony formation. The mycobacterial F-ATP synthase (left) is the target of the new chemical compound, which is shown to be potent in killing t… [+5907 chars]

full article...